SCHEMBL8869984

SCHEMBL8869984

CCCCCCNC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(C(=O)NCCO)nc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.55
P4HTM Q9NXG6 3/20 0.49
L3MBTL1 Q9Y468 1/20 0.48
NAAA Q02083 2/20 0.47
EGFR P00533 2/20 0.46
MLYCD O95822 1/20 0.45
KDM4E B2RXH2 1/20 0.45
SMPD1 P17405 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
CNR1 P21554 1/20 0.43
THRA P10827 1/20 0.42
THRB P10828 1/20 0.42
FLT1 P17948 1/20 0.42
FLT4 P35916 1/20 0.42
KDR P35968 1/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869156 0.96 P4HTM (0.51) CA2P4HTMEGFRKDM4ECA12
SCHEMBL8869547 0.91 CA2 (0.52) CA2P4HTML3MBTL1NAAAEGFR
SCHEMBL8868527 0.91 CA2 (0.52) CA2P4HTML3MBTL1NAAAEGFR
SCHEMBL9139174 0.91 P4HTM (0.62) CA2P4HTML3MBTL1NAAAEGFR
SCHEMBL8869712 0.89 CA2 (0.50) CA2P4HTML3MBTL1NAAAEGFR
SCHEMBL8868684 0.89 P4HTM (0.47) CA2P4HTML3MBTL1NAAASMPD1
SCHEMBL8868794 0.89 CA2 (0.50) CA2P4HTML3MBTL1NAAAEGFR
SCHEMBL8869078 0.89 P4HTM (0.53) CA2P4HTMEGFRKDM4ECA12
SCHEMBL9136947 0.89 CA2 (0.54) CA2P4HTML3MBTL1NAAAEGFR
SCHEMBL8869529 0.88 CA2 (0.48) CA2P4HTML3MBTL1NAAAEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed